Horizon receives European go-ahead for Ravicti
December 2, 2015Research and Development, Sales and Marketing Horizon Pharma, Ravicti, horizon, orphan drug, rare disease, urea cycle disorders
The European Commission has approved Ravicti for rare urea cycle disorders. Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …
Personalised care key to diabetes management, says NICE
December 2, 2015Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes
UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …
Pfizer lung cancer treatment gets expanded EU approval
December 1, 2015Research and Development, Sales and Marketing NSCLC, Pfizer, Xalkori, crizotinib, lung cancer, non-small cell lung cancer
Pfizer UK has received European Commission approval for a label update to expand use of Xalkori (crizotinib) to first-line treatment …
J&J announces new partnerships in fight against HIV/AIDS
December 1, 2015Research and Development AIDS, HIV, Janssen
Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …
PureTech names Nobel Laureate among new members of scientific advisory board
December 1, 2015Medical Communications, Research and Development PureTech Health, puretech
PureTech Health has compiled a scientific advisory board of distinguished scientists and physicians to expand its senior team. The scientific …
Investment in pharma manufacturing ‘key to driving UK economy’
December 1, 2015Manufacturing and Production economy, investment, manufacturing, production, robotics
Investing an additional £1.2 billion in UK manufacturing processes to increase robotics and automation could add as much as £60.5bn …
New web portal highlights UK strengths in medicines manufacturing
December 1, 2015Manufacturing and Production ABPI, KTN, Knowledge Transfer Network, Medicines Manufacturing Industry Partnership, UK, manufacturing, mmip, production
A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines …
Collaboration between MPP and University of Liverpool targets HIV nanomedicines
December 1, 2015Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines
The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …
EU approval for Gilead’s HIV combo Genvoya
December 1, 2015Manufacturing and Production, Sales and Marketing European Commission, Genvoya, Gilead, Gilead Sciences, HIV, TDF, World Aids Day, european union, taf
Gilead Sciences has won marketing authorisation from the European Commission (EC) for the once-daily single tablet regimen Genvoya as an …
FDA approves BMS and AbbVie’s Empliciti for multiple myeloma
December 1, 2015Manufacturing and Production, Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Empliciti, FDA, elotuzumab, multiple myeloma
The US healthcare regulator has approved Empliciti – a multiple myeloma treatment co-developed by Bristol-Myers Squibb and AbbVie. The FDA …
Laying bare the complexities of the pricing issue
November 30, 2015Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines
Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …
Clinigen launches UK managed access program for Takeda’s ixazomib
November 30, 2015Sales and Marketing Clinigen, Takeda, ixazomib, managed access, multiple myeloma, oncology
Clinigen and Takeda have struck a deal to allow patients in the UK to access the multiple myeloma drug ixazomib …
Ablynx appoints Robert Zeldin as new chief medical officer
November 30, 2015Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin
Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015. Dr Zeldin will lead …
Almirall to acquire Poli Group’s skin drugs
November 30, 2015Sales and Marketing Almirall, Poldi, dermatology, skin, specialty pharma
Almirall has agreed to acquire 100% of the share capital of Poli Group Holding as the Spanish pharma company continues …
Pharma company vows to plough profits back into R&D
November 30, 2015Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise
An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …
Bayer and Novartis to debut new data at ASH 2015
November 30, 2015Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology
Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …
SHL Creates Buzz at the 2015 PDA
November 30, 2015Medical Communications auto injectors, connectivity, pda, pen injectors, pre-filled drug delivery
With a newly designed booth to reflect SHL’s Scandinavian roots, SHL not only brought to this year’s PDA a booth …
Promoting diversity in the pharma industry: 10 female pharma rising stars
November 27, 2015Medical Communications, Sales and Marketing Jobs, Women in pharma, careers, diversity, pharmajobs, recruitment
While some parts of the pharma industry can be dominated by men there are plenty of women making waves in …
Sobi and Biogen’s haemophilia A treatment EU-approved
November 27, 2015Sales and Marketing Biogen, elocta, haemophilia a, sobi
Elocta, the haemophilia A treatment developed by the Swedish Orphan Biovitrum (Sobi) and Biogen, has received European Commission approval as …
Willy Simon joins Tiziana as non-executive director
November 27, 2015Research and Development Tiziana life sciences
Tiziana Life Sciences has appointed Willy Simon as a non-executive director who brings the benefit of a long and successful …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
